The Neuroendocrine Unit at the EVMS Strelitz Diabetes Center, directed by Aaron Vinik, MD, PhD, serves a global authority on autonomic and somatic neuropathy. Diabetic neuropathy (DN) is the leading cause of foot ulcers and amputations in diabetics patients, with an estimated rate of more than 50,000 non-traumatic amputations per year (CDC). DN is also a common cause of falls in the elderly.

It is the leading research unit in exploring the pathology and treatments for diabetic neuropathy. It was the first to use immune therapy as a treatment for DN. The Neuroendocrine Unit also serves as a coordinating center for many new therapeutic trials, providing sophisticated diagnostics and partnerships with superb laboratory support.